Slideshow
Author(s):
Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
Frontotemporal Dementia Insights From Baptist Health’s Brain and Spine Symposium
Episode 140: Down Syndrome and Alzheimer’s: Clinical Trials, Equity, and Patient-Centered Progress
This Week on NeurologyLive® — May 12, 2025
Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care
NeurologyLive® Friday 5 — May 9, 2025
Antidopaminergic Medications Worsen Outcomes in Huntington Disease, Study Shows